← Back to results

◐ Forecasted · RFA-RM-26-024

Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)

National Institutes of Health  ·  HHS

CFDA Numbers

93.310

Award Ceiling

$100K

Award Floor

$50K

Expected Awards

13

Close Date

Nov 10, 2026

Section I

How to Apply

View on grants_gov ↗

Program Contact


HumanVirome@od.nih.gov
Please contact via email.

Section II

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the human virome and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and its influence on health and disease. The purpose of this NOFO is to support small pilot projects that extend the goals of the HVP, including further validating, improving, and complementing existing and newly developed tools from the HVP program by leveraging human specimens collected from the cohorts under the program; samples from animals to promote the refinement, utilization, and translation of these tools to better serve the goals of the HVP program; expanding existing cohorts and/or biospecimen sampling sites for virome characterization; developing tools and methods to study the human virome; and defining interactions between the human virome and host. These pilot projects will encourage collaboration across the HVP and expand the consortium. Pilot projects should not overlap with existing HVP efforts. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.

Section IV

Key Dates

Posted
Sep 8, 2026
Closes
Nov 10, 2026